Completed NA INTERVENTIONAL 2-arm NCT03926039

Sharing Decision-making Program for HCC Patients Treatment Decisions

The Effectiveness of Sharing Decision-making Program Interventions in the Early Stage of HCC to Reduce Treatment Decisions Conflicts and Improving Decision-making Satisfaction

Sponsor: Lotung Poh-Ai Hospital

Conditions Hepatocellular Cancer

Interventions sharing decision-making program

Updated 12 times since 2019 Last updated: Oct 27, 2021 Started: May 1, 2019 Primary completion: Mar 6, 2020 Completion: Mar 6, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03926039, this NA trial focuses on Hepatocellular Cancer and remains completed. Sponsored by Lotung Poh-Ai Hospital, it has been updated 12 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Dec 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 7 earlier versions

Nov 2021 — Dec 2021 [monthly]

Completed NA
Oct 2021 — Nov 2021 [monthly]

Completed NA
Sep 2021 — Oct 2021 [monthly]

Completed NA
May 2021 — Sep 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — May 2021 [monthly]

Recruiting NA
Mar 2020 — Jan 2021 [monthly]

Recruiting NA
May 2019 — Mar 2020 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lotung Poh-Ai Hospital
National Taipei University of Nursing and Health Sciences

Data source: National Taipei University of Nursing and Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yilan, Taiwan